JP2024520644A5 - - Google Patents
Info
- Publication number
- JP2024520644A5 JP2024520644A5 JP2023574376A JP2023574376A JP2024520644A5 JP 2024520644 A5 JP2024520644 A5 JP 2024520644A5 JP 2023574376 A JP2023574376 A JP 2023574376A JP 2023574376 A JP2023574376 A JP 2023574376A JP 2024520644 A5 JP2024520644 A5 JP 2024520644A5
- Authority
- JP
- Japan
- Prior art keywords
- composition according
- cas
- page system
- cells
- cpp
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163196144P | 2021-06-02 | 2021-06-02 | |
| US63/196,144 | 2021-06-02 | ||
| PCT/US2022/031983 WO2022256546A2 (en) | 2021-06-02 | 2022-06-02 | Gene editing in primary immune cells using cell penetrating crispr-cas system |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024520644A JP2024520644A (ja) | 2024-05-24 |
| JP2024520644A5 true JP2024520644A5 (https=) | 2025-06-10 |
Family
ID=84324570
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023574376A Pending JP2024520644A (ja) | 2021-06-02 | 2022-06-02 | 細胞膜透過性ｃｒｉｓｐｒ－ｃａｓシステムを用いた初代免疫細胞における遺伝子編集 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20240263159A1 (https=) |
| EP (1) | EP4347811A4 (https=) |
| JP (1) | JP2024520644A (https=) |
| CN (1) | CN117795065A (https=) |
| AU (1) | AU2022283895A1 (https=) |
| CA (1) | CA3221125A1 (https=) |
| WO (1) | WO2022256546A2 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN117285599B (zh) * | 2023-10-11 | 2024-04-09 | 东北农业大学 | 一种抗胞内细菌的细胞穿透型抗菌肽5vt及其制备方法和应用 |
| WO2025208177A1 (en) * | 2024-04-03 | 2025-10-09 | Macquarie University | Therapeutic peptides |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10258697B2 (en) * | 2014-10-29 | 2019-04-16 | Massachusetts Eye And Ear Infirmary | Efficient delivery of therapeutic molecules in vitro and in vivo |
| WO2017175072A1 (en) * | 2016-04-08 | 2017-10-12 | Feldan Bio Inc. | Peptide shuttle based gene disruption |
| US12454685B2 (en) * | 2019-07-08 | 2025-10-28 | The Regents Of The University Of California | Variant type V CRISPR/Cas effector polypeptides and methods of use thereof |
-
2022
- 2022-06-02 WO PCT/US2022/031983 patent/WO2022256546A2/en not_active Ceased
- 2022-06-02 EP EP22816862.1A patent/EP4347811A4/en active Pending
- 2022-06-02 JP JP2023574376A patent/JP2024520644A/ja active Pending
- 2022-06-02 AU AU2022283895A patent/AU2022283895A1/en active Pending
- 2022-06-02 CA CA3221125A patent/CA3221125A1/en active Pending
- 2022-06-02 US US18/566,410 patent/US20240263159A1/en active Pending
- 2022-06-02 CN CN202280053796.XA patent/CN117795065A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12215366B2 (en) | Compositions and methods for epigenome editing | |
| US12410447B2 (en) | Engineered muscle targeting compositions | |
| JP7761294B2 (ja) | 遺伝子編集における非意図的な変異の阻害 | |
| KR102553518B1 (ko) | Hiv 감염의 rna-가이드된 치료를 위한 방법 및 조성물 | |
| JP2025181841A5 (https=) | ||
| JP2024520644A5 (https=) | ||
| US20220073950A1 (en) | Anellosomes for delivering protein replacement therapeutic modalities | |
| JP2017537611A5 (https=) | ||
| CA3231679A1 (en) | Hbb-modulating compositions and methods | |
| Dhungel et al. | Vaccinia virus as a master of host shutoff induction: targeting processes of the central dogma and beyond | |
| Carvalho et al. | Mutational analysis of the equine infectious anemia virus Tat-responsive element | |
| Schumann et al. | The impact of transposable element activity on therapeutically relevant human stem cells | |
| JP2025521581A (ja) | エピジェネティック編集用の組成物および方法 | |
| JP2022550141A5 (https=) | ||
| JP2025524456A (ja) | Ｂ２ｍ発現のエピジェネティック制御のための組成物および方法 | |
| WO2019060297A1 (en) | MITOCHONDRIAL REJUVENATION AS A TREATMENT FOR AGE-RELATED AND NEURODEGENERATIVE CONDITIONS | |
| JP2024528967A5 (https=) | ||
| CN115485305A (zh) | 癌细胞中裂解基因的激活 | |
| RU2482129C2 (ru) | Штамм вируса болезни ньюкасла для создания на его основе кандидатного противоракового препарата и изучения механизмов онколизиса | |
| CN118715322A (zh) | 酶、复合体、重组载体、遗传性疾病治疗药以及多核苷酸 | |
| CN121227875B (zh) | 一种抗病毒药物筛选标志物、微粒体甘油三酯转移蛋白抑制剂在制备抗病毒药物中的应用 | |
| US20260062700A1 (en) | Engineered retrons and methods of use | |
| TW202426060A (zh) | 經工程改造之逆轉錄子及使用方法 | |
| JP3325579B2 (ja) | 新規遺伝子組換え体 | |
| JP2025524455A (ja) | Ｔｒａｃ発現のエピジェネティック調節のための組成物及び方法 |